Clinical Trials Browser

Phase 1/2 × trifluridine tipiracil drug combination × 90 days × Clear all

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT04564898 2026-05-20

TriComB

Phase 1/2 Active not recruiting

48 enrolled

Gastrointestinal

Colorectal Cancer Metastatic

NCT07280377 2026-05-19

GOBLET

Phase 1/2 Active not recruiting

122 enrolled

Gastrointestinal

Anal Cancer Metastatic

NCT05083481 2026-05-05

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Phase 1/2 Active not recruiting

226 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04626635 2026-04-09

COMBINE-EGFR-1

Phase 1/2 Recruiting

933 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05927857 2026-04-09

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Phase 1/2 Recruiting

45 enrolled

Gastrointestinal

Metastatic Gastric Adenocarcinoma

NCT03223779 2026-03-12

Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer

Phase 1/2 Completed

52 enrolled

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

FOG-001 in Locally Advanced or Metastatic Solid Tumors

TriComB

GOBLET

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

COMBINE-EGFR-1

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer